ALS Model Glia Can Mediate Toxicity to Motor Neurons Derived from Human Embryonic Stem Cells

Cell Stem Cell

Volumn 3, Issue 6, 2008, Pages 575-576

  Hedlund, Eva ^a   Isacson, Ole ^b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; MUTANT PROTEIN; PROSTAGLANDIN; PROSTAGLANDIN INHIBITOR; REACTIVE OXYGEN METABOLITE;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LOSS; CELL MUTANT; CLINICAL TRIAL; COCULTURE; CYTOTOXICITY; DEGENERATIVE DISEASE; DISEASE COURSE; EMBRYONIC STEM CELL; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE MUTATION; GENETIC LINKAGE; GLIA CELL; HUMAN; HUMAN CELL CULTURE; INFLAMMATORY DISEASE; INTERNEURON; MOTOR NEURON DISEASE; MUTATIONAL ANALYSIS; NEUROPROTECTION; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FOLDING; SHORT SURVEY; SYMPTOM; TOXICOKINETICS; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTES; CELL COMMUNICATION; EMBRYONIC STEM CELLS; HUMANS; MODELS, BIOLOGICAL; MOTOR NEURONS; MUTATION; NERVE DEGENERATION; SUPEROXIDE DISMUTASE;

EID: 56549085570     PISSN: 19345909     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stem.2008.11.004     Document Type: Short Survey

References (11)

1. Boillee S., Vande Velde C., and Cleveland D.W. Neuron 52 (2006) 39-59
2. Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., and Eggan K. Nat. Neurosci. 10 (2007) 608-614
3. Di Giorgio F.P., Boulting G.L., Bobrowicz S., and Eggan K.C. Cell Stem Cell 3 (2008) 637-648 this issue
4. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., et al. Science 321 (2008) 1218-1221
5. Harraz M.M., Marden J.J., Zhou W., Zhang Y., Williams A., Sharov V.S., Nelson K., Luo M., Paulson H., Schoneich C., et al. J. Clin. Invest. 118 (2008) 659-670
6. Marchetto M.C.N., Muotri A.R., Mu Y., Smith A.M., Cezar G.G., and Gage F.H. Cell Stem Cell 3 (2008) 649-657 this issue
7. Martin L.J., Liu Z., Chen K., Price A.C., Pan Y., Swaby J.A., and Golden W.C. J. Comp. Neurol. 500 (2007) 20-46
8. Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., and Przedborski S. Nat. Neurosci. 10 (2007) 615-622
9. Nishitoh H., Kadowaki H., Nagai A., Maruyama T., Yokota T., Fukutomi H., Noguchi T., Matsuzawa A., Takeda K., and Ichijo H. Genes Dev. 22 (2008) 1451-1464
10. Pehar M., Cassina P., Vargas M.R., Castellanos R., Viera L., Beckman J.S., Estevez A.G., and Barbeito L. J. Neurochem. 89 (2004) 464-473
11. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., and Lee V.M. Proc. Natl. Acad. Sci. USA 93 (1996) 3155-3160